Impact of Microbiome in Endometriosis Development
ENDOBIOME
1 other identifier
observational
48
1 country
1
Brief Summary
Endometriosis is a chronic disease, of which the pathophysiology is still unknown. Several theories exist, the one of menstrual blood flow has been retained until now but does not fully explain it. The main symptoms are dysmenorrhea, dyspareunia and infertility. The aim of this study is to evaluate the impact of c.albicans colonization of vaginal microbioma in development of endometriosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2021
CompletedFirst Submitted
Initial submission to the registry
May 4, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedMay 8, 2026
May 1, 2026
12 months
May 4, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
vaginal dysbiosis with C. albicans
comparison of percentages between the two groups
At inclusion
Secondary Outcomes (4)
correlation between vaginal dysbioses and the presence of Candida hyphae
At inclusion
impact of endometriosis on HPVhr carrying
At inclusion
inflammatory biological markers involved in the endometriotic process
At inclusion
inflammatory biological markers involved in the endometriotic process
At inclusion
Study Arms (2)
case
Patient with confirmed or highly suspected endometriosis
Control
No confirmed or highly suspected endometriosis
Eligibility Criteria
women aged 18-50 years old
You may qualify if:
- For cases :
- aged 18-50 years old With confirmed or highly suspected endometriosis Affiliated to a social security system For controls: -aged 18-50 years old No confirmed or highly suspected Affiliated to a social security system
You may not qualify if:
- Minors; Pregnant women; Protected persons, or persons placed under the protection of justice; Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de la Guadeloupe
Les Abymes, Guadeloupe, 97159, Guadeloupe
Biospecimen
vaginal samples, buccal samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GÜLEN AYHAN, Doctor
CHU de la Guadeloupe
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2026
First Posted
May 8, 2026
Study Start
November 25, 2020
Primary Completion
November 17, 2021
Study Completion
November 17, 2021
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share